<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01187355</url>
  </required_header>
  <id_info>
    <org_study_id>C-09-074</org_study_id>
    <nct_id>NCT01187355</nct_id>
  </id_info>
  <brief_title>Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers</brief_title>
  <official_title>SiH MPDS FID 114675A Compared to Renu Fresh MPS in Symptomatic Contact Lens Wearers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two contact lens care solutions in symptomatic
      wearers of silicone hydrogel contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.</measure>
    <time_frame>Day 30</time_frame>
    <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.</measure>
    <time_frame>Day 30</time_frame>
    <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.</measure>
    <time_frame>Day 30</time_frame>
    <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">591</enrollment>
  <condition>Symptomatic Contact Lens Wearers</condition>
  <arm_group>
    <arm_group_label>Alcon MPDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MPDS used for 30 days as specified in protocol for contact lens care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>renu fresh MPS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>MPS used for 30 days as indicated for contact lens care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FID 114675A Multi-Purpose Disinfecting Solution (MPDS)</intervention_name>
    <description>Investigational multi-purpose disinfecting solution used by subjects as specified in use instructions provided for the care of study contact lenses, 30 days.</description>
    <arm_group_label>Alcon MPDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>renu fresh Multi-Purpose Solution (MPS)</intervention_name>
    <description>Commercially available multi-purpose solution used by subjects as indicated for care of study contact lenses, 30 days.</description>
    <arm_group_label>renu fresh MPS</arm_group_label>
    <other_name>renu® fresh™ Multi-Purpose Solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Contact lenses</intervention_name>
    <description>Contact lenses per subject's habitual brand and power worn for 30 days on a daily wear basis.</description>
    <arm_group_label>Alcon MPDS</arm_group_label>
    <arm_group_label>renu fresh MPS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic silicone hydrogel contact lens wearers who wear their lenses daily wear
             (i.e., disinfect lenses every night).

          -  Vision correctable to 20/30 or better with contact lenses.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Sensitivity to multi-purpose solutions.

          -  Use of any topical ocular OTC or prescribed topical ocular medications.

          -  History (6 months) or current ocular infections or ocular inflammatory events.

          -  Ocular surgery within the past year.

          -  Medical condition or use of medications that cause ocular side effects.

          -  Participation in any investigational study within the past 30 days.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2010</study_first_submitted>
  <study_first_submitted_qc>August 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2010</study_first_posted>
  <results_first_submitted>June 26, 2012</results_first_submitted>
  <results_first_submitted_qc>June 26, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 30, 2012</results_first_posted>
  <last_update_submitted>June 26, 2012</last_update_submitted>
  <last_update_submitted_qc>June 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Symptomatic, Contact lens care</keyword>
  <keyword>Multi-purpose solution</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited and enrolled from 42 US study centers.</recruitment_details>
      <pre_assignment_details>The Participant Flow Chart includes all randomized patients: 591. Baseline characteristics are presented for all subjects who received test article and had at least one on-regimen study visit: 578.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Alcon MPDS</title>
          <description>Multi-purpose disinfecting contact lens solution</description>
        </group>
        <group group_id="P2">
          <title>Renu Fresh MPS</title>
          <description>Multi-purpose contact lens solution</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="294"/>
                <participants group_id="P2" count="297"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="276"/>
                <participants group_id="P2" count="277"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Alcon MPDS</title>
          <description>Multi-purpose disinfecting contact lens solution</description>
        </group>
        <group group_id="B2">
          <title>Renu Fresh MPS</title>
          <description>Multi-purpose contact lens solution</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="288"/>
            <count group_id="B2" value="290"/>
            <count group_id="B3" value="578"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.5" spread="11.43"/>
                    <measurement group_id="B2" value="34.0" spread="11.24"/>
                    <measurement group_id="B3" value="34.3" spread="11.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                    <measurement group_id="B2" value="212"/>
                    <measurement group_id="B3" value="421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.</title>
        <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
        <time_frame>Day 30</time_frame>
        <population>All enrolled and dispensed subjects with an on-regimen follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Alcon MPDS</title>
            <description>Multi-purpose disinfecting contact lens solution</description>
          </group>
          <group group_id="O2">
            <title>Renu Fresh MPS</title>
            <description>Multi-purpose contact lens solution</description>
          </group>
        </group_list>
        <measure>
          <title>Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.</title>
          <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
          <population>All enrolled and dispensed subjects with an on-regimen follow-up visit.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
                <count group_id="O2" value="277"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="0.92"/>
                    <measurement group_id="O2" value="3.8" spread="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.</title>
        <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
        <time_frame>Day 30</time_frame>
        <population>All enrolled and dispensed subjects with an on-regimen follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Alcon MPDS</title>
            <description>Multi-purpose disinfecting contact lens solution</description>
          </group>
          <group group_id="O2">
            <title>Renu Fresh MPS</title>
            <description>Multi-purpose contact lens solution</description>
          </group>
        </group_list>
        <measure>
          <title>Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.</title>
          <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
          <population>All enrolled and dispensed subjects with an on-regimen follow-up visit.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
                <count group_id="O2" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.12"/>
                    <measurement group_id="O2" value="3.2" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.</title>
        <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
        <time_frame>Day 30</time_frame>
        <population>All enrolled and dispensed subjects with an on-regimen follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Alcon MPDS</title>
            <description>Multi-purpose disinfecting contact lens solution</description>
          </group>
          <group group_id="O2">
            <title>Renu Fresh MPS</title>
            <description>Multi-purpose contact lens solution</description>
          </group>
        </group_list>
        <measure>
          <title>Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.</title>
          <description>As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.</description>
          <population>All enrolled and dispensed subjects with an on-regimen follow-up visit.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="276"/>
                <count group_id="O2" value="277"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.13"/>
                    <measurement group_id="O2" value="3.1" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected for the duration of the study: 5 months, 2 weeks, 1 day.</time_frame>
      <desc>This reporting group includes all subjects enrolled and dispensed test article.</desc>
      <group_list>
        <group group_id="E1">
          <title>Alcon MPDS</title>
          <description>Multi-purpose disinfecting contact lens solution</description>
        </group>
        <group group_id="E2">
          <title>Renu Fresh MPS</title>
          <description>Multi-purpose contact lens solution</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="292"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Schizoaffective Disorder Bipolar Type</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="292"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Abortion Spontaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="292"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="292"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

